The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
November 16th 2024
Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with diabetes in the BPROAD trial.
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Stroke Treatment Without Thrombolytic Therapy, New Research
August 14th 2019Stimulating the sphenopalatine ganglion-a collection of nerve cells closely associated with the trigeminal nerve most responsible for headaches-could be a safe intervention for patients with acute ischemic stroke who aren’t eligible for thrombolytic therapy, researchers report in The Lancet.
U.S. Ranks High in Hypertension Awareness, Treatment and Control
August 14th 2019Awareness of the prevalence of hypertension has increased substantially over the past 40 years in high-income countries, as has treatment and control of the condition. But, the level of control falls short of rates seen in dedicated hypertension programs, and it’s stagnating, according to research published last month in The Lancet.
FDA Decision on Icosapent sNDA Delayed for Advisory Committee Meeting
August 9th 2019The committee meeting, tentatively scheduled for November 14, will have to precede the sNDA PDUFA action date set to review the drug's potential indication for reducing residual cardiovascular risks in patients with elevated triglycerides.
Definitive Evidence Supports Plant-Based Diet to Control Diabetes
A systematic review and meta-analysis of observational studies assessing the association between plant-based dietary patterns and the risk of type 2 diabetes among adults, provides the strongest evidence to date that eating a plant-based diet does indeed lower the risk of type 2 diabetes.
Treatment Delays Onset of Diabetes in At-Risk Populations
A single course of treatment with teplizumab delayed the development of type 1 diabetes in at-risk teens and children, shows a study presented at the American Diabetes Association annual meeting earlier this month.
Young Adult Type 2 Diabetes Increasingly Associated with Serious Complications
Diabetes complications in young adults with type 2 diabetes are occurring in unusually high rates, researchers reported at the American Diabetes Association annual meeting held earlier this month in San Francisco.